Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (opent nieuw venster)

Barillari G, Pasca S, Barillari A, De Angelis V.

Bron‎: Blood Transfus 2012;10(1):87-94.

Geïndexeerd‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (opent nieuw venster)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (opent nieuw venster)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Bron‎: Chest 2012;141(2 Suppl):e326S-50S.

Geïndexeerd‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (opent nieuw venster)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (opent nieuw venster)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Bron‎: Lancet 2015;385(9982):2077-87.

Geïndexeerd‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (opent nieuw venster)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (opent nieuw venster)

Hanke AA, Joch C, Görlinger K.

Bron‎: Br J Anaesth 2013;110(5):764-72.

Geïndexeerd‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (opent nieuw venster)

Emergency reversal of warfarin anticoagulation. (opent nieuw venster)

Lin Y, Callum J.

Bron‎: CMAJ 2010;182(18):2004.

Geïndexeerd‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (opent nieuw venster)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (opent nieuw venster)

Mo Y, Yam FK.

Bron‎: Pharmacotherapy 2015;35(2):198-207.

Geïndexeerd‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (opent nieuw venster)

Idarucizumab for dabigatran reversal - full cohort analysis. (opent nieuw venster)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Bron‎: N Engl J Med 2017;377(5):431-41.

Geïndexeerd‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (opent nieuw venster)

Oral anticoagulation in surgical procedures: risks and recommendations. (opent nieuw venster)

Torn M, Rosendaal FR.

Bron‎: Br J Haematol 2003;123(4):676-82.

Geïndexeerd‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (opent nieuw venster)